retatrutide clinical trial results 2024 2025 press release Retatrutide—A Game Changer in Obesity Pharmacotherapy Eli Lilly infiltrates anti-obesity market

Semaglutide (Wegovy) and tirzepatide (Mounjaro) have been proven to help people lose weight and are most effective when taken alongside a diet and exercise plan

ROR = reporting odds ratio

The severity and duration of these side effects vary considerably between individuals

For example, cholesterol binding sites were identified in the adenosine A 2A receptor

Lead study author, Hamlet Gasoyan, DS, PhD, MPH, a researcher with Cleveland Clinics Center for Value-Based Care Research, spoke to Medical News Today , emphasizing the importance of these results in a real-world setting: Randomized clinical trials documented that discontinuation of novel obesity medications generally leads patients to regain weight, Gasoyan told us